{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:38:17Z","timestamp":1762508297651,"version":"build-2065373602"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.critrevonc.2020.103175","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T12:46:26Z","timestamp":1605617186000},"page":"103175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Current overview and special considerations for second breast cancer in Hodgkin lymphoma survivors"],"prefix":"10.1016","volume":"157","author":[{"given":"Joaira","family":"Bakkach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedetta","family":"Pellegrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagar","family":"Elghazawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Novosad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjit","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohcine","family":"Bennani Mechita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2020.103175_bib0005","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nrc1749","article-title":"Mechanisms of therapy-related carcinogenesis","volume":"5","author":"Allan","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ncponc1135","article-title":"Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin\u2019s lymphoma","volume":"5","author":"Alm El-Din","year":"2008","journal-title":"Nat. Clin. Pract. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijrobp.2008.03.066","article-title":"Breast Cancer After treatment of hodgkin\u2019s lymphoma: risk factors that really matter","volume":"73","author":"Alm El-Din","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1748-717X-4-19","article-title":"Clinical outcome of breast cancer occurring after treatment for Hodgkin\u2019s lymphoma: case-control analysis","volume":"4","author":"Alm El-Din","year":"2009","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0025","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bjc.6604244","article-title":"Family history of cancer as a risk factor for second malignancies after Hodgkin\u2019s lymphoma","volume":"98","author":"Andersson","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0030","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.ijrobp.2016.09.054","article-title":"NRG Oncology\/RTOG 1014: 3 year efficacy report from a phase II study of repeat breast preserving surgery and 3D conformal partial breast Re-Irradiation (PBrI) for in-breast recurrence","volume":"96","author":"Arthur","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00006534-200201000-00017","article-title":"Breast reconstruction using tissue expanders and implants in Hodgkin\u2019s patients with prior mantle irradiation","volume":"109","author":"Bacilious","year":"2002","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0040","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3332\/ecancer.2018.810","article-title":"Secondary breast cancer after Hodgkin lymphoma: a case report and literature review","volume":"12","author":"Bakkach","year":"2018","journal-title":"Ecancermedicalscience"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0045","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/annonc\/mdr013","article-title":"Reduced incidence of second solid tumors in survivors of childhood Hodgkin\u2019s lymphoma treated without radiation therapy","volume":"22","author":"Barbaro","year":"2011","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0050","first-page":"1027","article-title":"Molecular changes in second primary lung and breast cancers after therapy for Hodgkin\u2019s disease","volume":"9","author":"Behrens","year":"2000","journal-title":"Cancer Epidemiol. Prev. Biomark."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0055","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nm.2407","article-title":"Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin\u2019s lymphoma","volume":"17","author":"Best","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0060","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clbc.2013.06.001","article-title":"Prophylactic mastectomy: a treatment alternative for hodgkin survivors?","volume":"13","author":"Boucher","year":"2013","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0065","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ijrobp.2009.09.004","article-title":"Radiation-associated breast tumors display a distinct gene expression profile","volume":"76","author":"Broeks","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13566-016-0262-7","article-title":"Comparison of treatment modalities for breast cancer arising in Hodgkin\u2019s lymphoma survivors","volume":"6","author":"Burt","year":"2017","journal-title":"J. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0075","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/carcin\/21.4.769","article-title":"Establishment of a radiation- and estrogen-induced breast cancer model","volume":"21","author":"Calaf","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/1078-0432.CCR-06-1490","article-title":"Radiation effects on development of HER2-Positive breast carcinomas","volume":"13","author":"Castiglioni","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0085","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/COC.0b013e318180c880","article-title":"Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin\u2019s disease","volume":"32","author":"Chadha","year":"2009","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13566-012-0073-4","article-title":"Patterns of relapse and risk for new malignancies following partial breast re-irradiation","volume":"2","author":"Chadha","year":"2013","journal-title":"J. Radiat. Oncol."},{"year":"2018","series-title":"Long-term Follow-up Guidelines for Survivors of Childhood, Adolescent, and Young Adult cancers.VErsion 5.0-October","author":"Children\u2019s Oncology Group","key":"10.1016\/j.critrevonc.2020.103175_bib0095"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0100","first-page":"7","article-title":"Evaluation of partial breast reirradiation with intraoperative radiotherapy after prior thoracic radiation: a single-institution report of outcomes and toxicity","author":"Chin","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0105","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1158\/0008-5472.CAN-12-1728","article-title":"Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms","volume":"72","author":"Choi","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0110","first-page":"5","article-title":"Abstract: outcomes following breast reconstruction in patients with prior mantle radiation for treatment of hodgkin\u2019s lymphoma","author":"Chun","year":"2017","journal-title":"Plast. Reconstr. Surg. Glob. Open"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/ctrv.2000.0174","article-title":"Breast cancer risk following irradiation for Hodgkin\u2019s disease","volume":"26","author":"Clemons","year":"2000","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijrobp.2016.10.004","article-title":"Secondary breast Cancer risk by radiation volume in women with hodgkin lymphoma","volume":"97","author":"Conway","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0125","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1038\/bjc.2013.219","article-title":"Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors","volume":"108","author":"Cooke","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-8140(01)00337-1","article-title":"Breast cancer occurred after treatment for Hodgkin\u2019s disease: analysis of 133 cases","volume":"59","author":"Cutuli","year":"2001","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.critrevonc.2011.01.005","article-title":"Breast cancer occurred after Hodgkin\u2019s disease: clinico-pathological features, treatments and outcome: analysis of 214 cases","volume":"81","author":"Cutuli","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0140","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1200\/JCO.2008.19.9174","article-title":"Breast Cancer risk in female survivors of hodgkin\u2019s lymphoma: lower risk after smaller radiation volumes","volume":"27","author":"De Bruin","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0145","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.2017.476","article-title":"High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors","author":"de Vries","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0150","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0360-3016(02)02785-2","article-title":"Repeat high-dose external beam irradiation for in-breast tumor recurrence after previous lumpectomy and whole breast irradiation","volume":"53","author":"Deutsch","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00000421-200102000-00005","article-title":"Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin\u2019s disease or lymphoma","volume":"24","author":"Deutsch","year":"2001","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0160","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2009.01.040","article-title":"Frequency Distribution of Second Solid Cancer Locations in Relation to the Irradiated Volume Among 115 Patients Treated for Childhood Cancer","volume":"74","author":"Diallo","year":"2009","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0165","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2002.08.031","article-title":"Breast Cancer screening in women previously treated for hodgkin\u2019s disease: a prospective cohort study","volume":"20","author":"Diller","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0170","article-title":"A feasibility study of tamoxifen chemoprevention in Hodgkin\u2019s disease (HD) survivors","author":"Diller","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0175","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of hodgkin\u2019s disease: a population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0180","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.bjc.6605877","article-title":"Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin\u2019s lymphoma treated with radiotherapy","volume":"103","author":"Dores","year":"2010","journal-title":"Br. J. Cancer"},{"year":"2010","series-title":"Richtlijn Follow-up Nakinderkankermeerdan 5 Jaarna Diagnose. SKION, Den Haag\/Amsterdam, the Netherlands","author":"Dutch Childhood Oncology Group","key":"10.1016\/j.critrevonc.2020.103175_bib0185"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0190","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.2010.32.4079","article-title":"Characteristics and outcomes of breast Cancer in women with and without a history of radiation for hodgkin\u2019s lymphoma: a multi-institutional, matched cohort study","volume":"29","author":"Elkin","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0195","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1634\/theoncologist.2016-0460","article-title":"Male breast Cancer as a second primary Cancer: increased risk following lymphoma","volume":"22","author":"Farr","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0200","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/rpd\/nci766","article-title":"Mammographic breast cancer screening for women previously treated with high breast doses for diseases such as Hodgkin\u2019s","volume":"117","author":"Faulkner","year":"2005","journal-title":"Radiat. Prot. Dosimetry"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0205","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1093\/annonc\/mdl302","article-title":"Second malignancy risk associated with treatment of Hodgkin\u2019s lymphoma: meta-analysis of the randomised trials","volume":"17","author":"Franklin","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0210","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jnci\/djz037","article-title":"Cost-utility of early breast Cancer surveillance in survivors of thoracic radiation-treated adolescent hodgkin lymphoma","volume":"112","author":"Furzer","year":"2020","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0215","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0360-3016(00)01481-4","article-title":"Breast cancer after mantle irradiation for Hodgkin\u2019s disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2","volume":"49","author":"Gaffney","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0220","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/j.ijrobp.2011.03.013","article-title":"Locoregional treatment for breast carcinoma after hodgkin\u2019s lymphoma: the breast conservation option","volume":"82","author":"Haberer","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0225","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2013.03.026","article-title":"Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer working Group","volume":"108","author":"Hannoun-Levi","year":"2013","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0230","doi-asserted-by":"crossref","first-page":"444","DOI":"10.7326\/0003-4819-152-7-201004060-00009","article-title":"Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer","volume":"152","author":"Henderson","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0235","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1182\/blood-2005-04-1535","article-title":"Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors","volume":"106","author":"Hill","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0240","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/cncr.25053","article-title":"A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects","volume":"116","author":"Hodgson","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0245","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw010","article-title":"Impact of early breast Cancer Screening on mortality among young survivors of Childhood Hodgkin\u2019s Lymphoma","volume":"108","author":"Hodgson","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0250","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2011.06.1959","article-title":"Consolidative involved-node proton therapy for stage IA-IIIB mediastinal hodgkin lymphoma: preliminary dosimetric outcomes from a phase II study","volume":"83","author":"Hoppe","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0255","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/annonc\/mdu017","article-title":"Histologic subtypes of breast cancer following radiotherapy for Hodgkin lymphoma","volume":"25","author":"Horst","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0260","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.bjc.6605215","article-title":"The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage","volume":"101","author":"Howell","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0265","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/1471-2407-12-197","article-title":"Risk of second breast cancer in female Hodgkin\u2019s lymphoma survivors: a meta-analysis","volume":"12","author":"Ibrahim","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0270","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1200\/JCO.2008.20.7738","article-title":"Radiation dose and breast Cancer risk in the childhood Cancer survivor study","volume":"27","author":"Inskip","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0275","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2015.11.046","article-title":"Radiation-Related New Primary Solid Cancers in the Childhood Cancer Survivor Study: Comparative Radiation Dose Response and Modification of Treatment Effects","volume":"94","author":"Inskip","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0280","series-title":"Breast Cancer","first-page":"399","article-title":"Breast cancer in lymphoma survivors","author":"Intra","year":"2017"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0285","doi-asserted-by":"crossref","first-page":"R828","DOI":"10.1186\/bcr1310","article-title":"A new option for early breast cancer patients previously irradiated for Hodgkin\u2019s disease: intraoperative radiotherapy with electrons (ELIOT)","volume":"7","author":"Intra","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0290","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0960-9776(11)70304-6","article-title":"Local therapy for breast cancer in malignant lymphoma survivors","volume":"20","author":"Intra","year":"2011","journal-title":"Breast"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0295","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/SLA.0000000000001177","article-title":"Complications after mastectomy and immediate breast reconstruction for breast Cancer: a claims-based analysis","volume":"263","author":"Jagsi","year":"2016","journal-title":"Ann. Surg."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0300","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1046\/j.1524-4741.2001.007001046.x","article-title":"Clinical and pathologic features of breast cancers in women treated for hodgkin\u2019s disease: a case-control study","volume":"7","author":"Janov","year":"2001","journal-title":"Breast J."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0305","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.radonc.2011.07.020","article-title":"Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial","volume":"102","author":"Kauer-Dorner","year":"2012","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0310","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-141-8-200410190-00006","article-title":"Breast cancer after childhood cancer: a report from the Childhood Cancer survivor Study","volume":"141","author":"Kenney","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0315","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1748-717X-2-13","article-title":"A comparison of mantle versus involved-field radiotherapy for Hodgkin\u2019s lymphoma: reduction in normal tissue dose and second cancer risk","volume":"2","author":"Koh","year":"2007","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0320","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1245\/s10434-015-4596-y","article-title":"Management and prevention of breast cancer after radiation to the chest for childhood, adolescent, and young adulthood malignancy","volume":"22","author":"Koo","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0325","first-page":"7","article-title":"Intraoperative radiotherapy (IORT) is an option for patients with localized breast recurrences after previous external-beam radiotherapy","author":"Kraus-Tiefenbacher","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0330","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.ijrobp.2017.07.016","article-title":"Breast Cancer risk after radiation therapy for hodgkin lymphoma: influence of gonadal hormone exposure","volume":"99","author":"Krul","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0335","doi-asserted-by":"crossref","first-page":"e391","DOI":"10.1002\/mp.12462","article-title":"AAPM TG 158: measurement and calculation of doses outside the treated volume from external-beam radiation therapy","volume":"44","author":"Kry","year":"2017","journal-title":"Med. Phys."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0340","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ijc.22414","article-title":"Risk of second malignant neoplasms among lymphoma patients with a family history of cancer","volume":"120","author":"Landgren","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0345","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1200\/JCO.2004.11.032","article-title":"Development of risk-based guidelines for pediatric Cancer survivors: the children\u2019s oncology group long-term follow-up guidelines from the children\u2019s oncology group late effects committee and nursing discipline","volume":"22","author":"Landier","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13014-019-1360-7","article-title":"Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin\u2019s disease","volume":"14","author":"Lautenschlaeger","year":"2019","journal-title":"Radiat. Oncol."},{"year":"2020","series-title":"Clinicaltrials.Gov. Identifier: NCT01196936","author":"Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors (LDTam)","key":"10.1016\/j.critrevonc.2020.103175_bib0355"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0360","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2011-10-383380","article-title":"FGFR2 genotype and risk of radiation-associated breast cancer in Hodgkin lymphoma","volume":"119","author":"Ma","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0365","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/pbc.24861","article-title":"The impact of involved node, involved field and mantle field radiotherapy on estimated radiation doses and risk of late effects for pediatric patients with Hodgkin lymphoma: radiotherapy for Pediatric Hodgkin Lymphoma","volume":"61","author":"Maraldo","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0370","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1524-4741.2010.00904.x","article-title":"Breast cancer following Hodgkin\u2019s Disease: the experience of the university of florence","volume":"16","author":"Meattini","year":"2010","journal-title":"Breast J."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0375","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2010.29.5683","article-title":"Long-term survival among patients with hodgkin\u2019s lymphoma who developed breast Cancer: a population-based study","volume":"28","author":"Milano","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0380","first-page":"109","article-title":"Genome-wide association study to identify susceptibility loci that modify radiation-related risk for breast Cancer After childhood Cancer","author":"Morton","year":"2017","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0385","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast Cancer After chest radiation therapy for childhood Cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0390","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/bjc.2017.169","article-title":"Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study","volume":"117","author":"Moskowitz","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0395","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1200\/JCO.18.02219","article-title":"Mortality after breast Cancer Among survivors of childhood Cancer: a report from the childhood Cancer survivor study","volume":"37","author":"Moskowitz","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0400","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1016\/S1470-2045(13)70303-6","article-title":"Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer guideline Harmonization Group","volume":"14","author":"Mulder","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0405","doi-asserted-by":"crossref","first-page":"442","DOI":"10.7326\/0003-4819-153-7-201010050-00007","article-title":"Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"153","author":"Nathan","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0410","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11764-013-0271-0","article-title":"Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer","volume":"7","author":"Nathan","year":"2013","journal-title":"J. Cancer Surviv."},{"year":"2014","series-title":"Breast Cancer.Version 3.","author":"NCCN Clinical Practice Guidelines in Oncology","key":"10.1016\/j.critrevonc.2020.103175_bib0415"},{"year":"2018","series-title":"Breast Cancer.Version 4.","author":"NCCN Clinical Practice Guidelines in Oncology","key":"10.1016\/j.critrevonc.2020.103175_bib0420"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0425","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1200\/JCO.2012.46.5732","article-title":"Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin Lymphoma","volume":"31","author":"Ng","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0430","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s10549-009-0421-2","article-title":"Breast-conserving therapy after previous irradiation for lymphoma","volume":"124","author":"Nguyen","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0435","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1200\/JCO.2003.12.042","article-title":"TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of hodgkin\u2019s disease with second primary neoplasms","volume":"21","author":"Nichols","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0440","series-title":"Seminars in Radiation Oncology","first-page":"200","article-title":"Tissue tolerance to reirradiation","author":"Nieder","year":"2000"},{"issue":"suppl","key":"10.1016\/j.critrevonc.2020.103175_bib0445","article-title":"The EMPOWER study: promoting breast cancer screening\u2014a randomized controlled trial (RCT) in the Childhood Cancer survivor Study (CCSS)","volume":"34","author":"Oeffinger","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0450","first-page":"3813","article-title":"Rare variants of ATM and risk for Hodgkin\u2019s disease and radiation-associated breast cancers","volume":"8","author":"Offit","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0455","unstructured":"Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17. ClinicalTrials.gov Identifier: NCT03755804. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03755804?term=response+adapted&cond=Hodgkin+Lymphoma&draw=5&rank=10. [Accessed April 3 2019]."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0460","unstructured":"Radiation therapy in treating women with locally recurrent breast cancer previously treated with repeat breast-preserving surgery. Clinicaltrials.Gov. Identifier: NCT01082211. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01082211. [Accessed March 29, 2019]."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0465","unstructured":"Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma. ClinicalTrials.gov Identifier: NCT01118026. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01118026?term=response+adapted&cond=Hodgkin+Lymphoma&draw=3&rank=14. [Accessed April 3, 2019]."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0470","first-page":"20","article-title":"Retrospective methods to estimate radiation dose at the site of breast cancer development after Hodgkin lymphoma radiotherapy","volume":"7","author":"Russell","year":"2017","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0475","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/annonc\/mdl399","article-title":"Breast cancer in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma survivors","volume":"18","author":"Sanna","year":"2006","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0480","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second Cancer risk up to 40 years after treatment for hodgkin\u2019s lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N. Engl. J. Med."},{"year":"2013","series-title":"Long Term Follow up of Survivors of Childhood Cancer. A National Clinical Guideline, March","author":"Scottish Intercollegiate Guidelines Network","key":"10.1016\/j.critrevonc.2020.103175_bib0485"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0490","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","article-title":"Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Senkus","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0495","first-page":"8","article-title":"Estrogen enhanced cell-cell signalling in breast cancer cells exposed to targeted irradiation","author":"Shao","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0500","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.2016.70.9709","article-title":"Risk of second Cancer in hodgkin lymphoma survivors and influence of family history","volume":"35","author":"Sud","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0505","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1200\/JCO.2011.34.8268","article-title":"Second Cancer risk after chemotherapy for Hodgkin\u2019s lymphoma: a collaborative british cohort study","volume":"29","author":"Swerdlow","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0510","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1200\/JCO.2011.38.8835","article-title":"Breast Cancer risk after supradiaphragmatic radiotherapy for hodgkin\u2019s lymphoma in England and Wales: a national cohort study","volume":"30","author":"Swerdlow","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0515","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.ejca.2015.05.024","article-title":"Management of breast cancer after Hodgkin\u2019s lymphoma and paediatric cancer","volume":"51","author":"Terenziani","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0520","unstructured":"The American Society of Breast Surgeons. Performance and Practice Guidelines for Breast-Conserving Surgery\/Partial Mastectomy. https:\/\/www.breastsurgeons.org\/about\/statements\/. [Accessed March 29 2019]."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0525","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast Cancer Following radiotherapy and chemotherapy among young women with hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0530","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2017.0693","article-title":"Temporal trends in treatment and subsequent neoplasm risk among 5-Year survivors of childhood Cancer, 1970-2015","volume":"317","author":"Turcotte","year":"2017","journal-title":"JAMA"},{"year":"2011","series-title":"Therapy Based Long Term Follow up Practice Statement","author":"United Kingdom Children\u2019s Cancer Study Group Late Effects Group","key":"10.1016\/j.critrevonc.2020.103175_bib0535"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0540","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin\u2019s disease","volume":"95","author":"Van Leeuwen","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0545","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1634\/theoncologist.2011-0451","article-title":"Risk, characteristics, and prognosis of breast Cancer after hodgkin\u2019s lymphoma","volume":"17","author":"Veit-Rubin","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0550","series-title":"Mayo Clinic Proceedings","first-page":"708","article-title":"Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo clinic experience","author":"Wahner-Roedler","year":"2003"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0555","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f1190","article-title":"Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance","volume":"346","author":"Wallace","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.critrevonc.2020.103175_bib0560","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ijrobp.2010.05.035","article-title":"Predicted risk of radiation-induced cancers after involved field and involved node radiotherapy with or without intensity modulation for early-stage hodgkin lymphoma in female patients","volume":"81","author":"Weber","year":"2011","journal-title":"Int. J. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2020.103175_bib0565","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1001\/jamaoncol.2017.4887","article-title":"Association of treatment for hodgkin lymphoma with estrogen receptor status of subsequent breast cancers","volume":"4","author":"Withrow","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0570","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1200\/JCO.1998.16.2.536","article-title":"Second cancers following pediatric Hodgkin\u2019s disease","volume":"16","author":"Wolden","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0575","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2000.18.4.765","article-title":"Management of breast cancer after Hodgkin\u2019s disease","volume":"18","author":"Wolden","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0580","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/SAP.0000000000000167","article-title":"Outcomes of breast reconstruction in breast cancer patients with a history of mantle radiation for Hodgkin lymphoma","volume":"72","author":"Wong","year":"2014","journal-title":"Ann. Plast. Surg."},{"key":"10.1016\/j.critrevonc.2020.103175_bib0585","article-title":"Characterization of genomic alterations in radiation-associated breast Cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820303115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842820303115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:44:47Z","timestamp":1760903087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842820303115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":117,"alternative-id":["S1040842820303115"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103175","relation":{},"ISSN":["1040-8428"],"issn-type":[{"type":"print","value":"1040-8428"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current overview and special considerations for second breast cancer in Hodgkin lymphoma survivors","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2020.103175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103175"}}